220 related articles for article (PubMed ID: 7605242)
1. [Vasodilators in heart failure. Basis for their use].
Mesquita ET; Mady C
Arq Bras Cardiol; 1994 Dec; 63(6):531-6. PubMed ID: 7605242
[No Abstract] [Full Text] [Related]
2. Abnormalities of diastolic function as a potential cause of exercise intolerance in chronic heart failure.
Packer M
Circulation; 1990 Feb; 81(2 Suppl):III78-86. PubMed ID: 1967559
[TBL] [Abstract][Full Text] [Related]
3. [Diastolic cardiac insufficiency].
Spoto S; Palma Modoni A; De Galasso L
Clin Ter; 2002; 153(5):355-7. PubMed ID: 12510423
[No Abstract] [Full Text] [Related]
4. [The treatment of cardiac insufficiency with vasodilators].
Biollaz J; Munafo A
Schweiz Med Wochenschr; 1988 Apr; 118(17):616-20. PubMed ID: 3381076
[TBL] [Abstract][Full Text] [Related]
5. [Therapy of hypertensive heart disease: vasodilator agents in the forefront].
Bolli P; Bühler FR
Ther Umsch; 1984 Feb; 41(2):150-5. PubMed ID: 6200947
[No Abstract] [Full Text] [Related]
6. [Drug therapy of congestive heart failure].
Sasayama S
Nihon Naika Gakkai Zasshi; 1997 Sep; 86(9):1770-7. PubMed ID: 9410998
[No Abstract] [Full Text] [Related]
7. Vasodilator therapy for congestive heart failure. Lessons from mortality trials.
Groden DL
Arch Intern Med; 1993 Feb; 153(4):445-54. PubMed ID: 8435024
[TBL] [Abstract][Full Text] [Related]
8. Therapy for congestive heart failure in the late 20th century.
Maxwell LP; Jain A
W V Med J; 1993 Apr; 89(4):148-51. PubMed ID: 8098171
[TBL] [Abstract][Full Text] [Related]
9. Assessing the treatment of congestive heart failure: diuretics, vasodilators, and angiotensin-converting enzyme inhibitors.
Chow MS
Pharmacotherapy; 1993; 13(5 Pt 2):82S-87S. PubMed ID: 8233997
[TBL] [Abstract][Full Text] [Related]
10. Congestive heart failure. Pathophysiology and treatment. Part Three.
Panetta F
Aust Fam Physician; 1987 Mar; 16(3):327, 331-2. PubMed ID: 3038064
[No Abstract] [Full Text] [Related]
11. [Exercise test in the evaluation of the efficacy of drug therapy].
Febo O; Cobelli F
Ital Heart J Suppl; 2000 Mar; 1(3):393-9. PubMed ID: 10815269
[No Abstract] [Full Text] [Related]
12. [Vasodilator treatment of chronic heart failure].
Woroszylska M
Kardiol Pol; 1983; 26(10):741-51. PubMed ID: 6141316
[No Abstract] [Full Text] [Related]
13. Optimal treatment of hypertension with diastolic heart failure.
Susic D; Frohlich ED
Heart Fail Clin; 2008 Jan; 4(1):117-24. PubMed ID: 18313629
[TBL] [Abstract][Full Text] [Related]
14. Clinical issues in the management of heart failure.
Boccanelli A; Scardovi AB
G Ital Cardiol; 1999 Oct; 29(10):1195-8. PubMed ID: 10546133
[No Abstract] [Full Text] [Related]
15. [New knowledge on the subject of therapy in cardiac decompensation in the light of large trials].
Camerini F; Perkan A; Sinagra G; Di Lenarda A; Pinamonti B; Zecchin M
Ann Ital Med Int; 1994 Oct; 9 Suppl():68S-77S. PubMed ID: 7857761
[TBL] [Abstract][Full Text] [Related]
16. [Refractory heart failure: it requires the use of polychemotherapy. What is the rationale?].
Campa PP; Puddu PE; Schiariti M; Monti F; Dawodu AA; Gentile C; Lilla Della Monica PL; Vaccaro M; De Biase L
Cardiologia; 1995 Dec; 40(12 Suppl 1):139-50. PubMed ID: 8998706
[No Abstract] [Full Text] [Related]
17. [Use of vasodilator agents in the treatment of cardiac insufficiency].
Ruano Calvo FJ; Larman Tellechea M; Pajarón López A
Med Clin (Barc); 1984 Oct; 83(11):460-8. PubMed ID: 6150138
[No Abstract] [Full Text] [Related]
18. Congestive heart failure. Drug therapy: central or peripheral approach?
Remme WJ
Cardiologia; 1993 Dec; 38(12 Suppl 1):51-9. PubMed ID: 7912652
[TBL] [Abstract][Full Text] [Related]
19. Surrogate end points in heart failure trials.
Gheorghiade M; Adams KF; Gattis WA; Teerlink JR; Orlandi C; O'Connor CM
Am Heart J; 2003 Feb; 145(2 Suppl):S67-70. PubMed ID: 12594457
[No Abstract] [Full Text] [Related]
20. Therapeutic options in the management of chronic heart failure. Is there a drug of first choice?
Packer M
Circulation; 1989 Jan; 79(1):198-204. PubMed ID: 2562938
[No Abstract] [Full Text] [Related]
[Next] [New Search]
